CD4 and esophageal cancer: The percentage of CD4+ TILs expressing BTLA was significantly lower than that of circulating CD4+ T cells from esophageal cancer patients (91.73 ± 0.7573% vs. 95.46 ± 1.438%, p = 0.0199).